Health market

from Wikipedia, the free encyclopedia

The health market is part of the health economy , the largest branch of all industrialized countries worldwide. In Germany, as of 2007/2008, around 4.4 million people were working in this branch and thus every tenth employee subject to social security contributions. The main drivers of this “market” are medical-technical innovations, increasing life expectancy with a corresponding increase in diseases, and population development, particularly Germany's demography . However, the forces of the health market are subject to emphatic state regulation with a large number of amendments since 1976 and health reforms at the legislative level, especially in the social code .

interpretation

While the term health care serves more to describe the extremely complex health care system of our health care, the health care industry as a whole does not only include the predominantly publicly financed and state-regulated, direct inpatient and outpatient care of the sick, which - depending on the point of view - economically only includes around a quarter of the total “Market” of this industry . The healthcare market is considered to be the largest and at the same time most expansive growth and employment engine of all German industries. Modern advocates of the Kondratiev theory such as Leo Nefiodow or later Erik Händeler see the increasing economic importance of health-related products as a sign that the basic innovation for the next long-term upturn lies in this sector.

structuring

In the past, profitable production and service sectors in health care (e.g. pharmaceutical and medical product manufacturers) were assigned to industry. B. Health care. In addition, there was "Life Science", the life sciences that were promoted as promising research areas. It is now completely undisputed that the different areas belong together and only two sides of the same coin correspond to the “ health economy ”. These are clearly divided into core area, wholesale and supplier area as well as health-relevant marginal areas in the "onion model of the health economy" by Elke Dahlbeck and Josef Hilbert from the "Institute for Work and Technology (IAT)" in Gelsenkirchen. The core area of ​​the health economy is also referred to as the "first health market". This is largely financed by statutory and private health insurance (including long-term care insurance). The so-called “second health market” describes all privately financed products and services related to health. From the patient's perspective, for example, individual health services - IGeL - are typical market elements in the second health market.

Pharmaceutical market

In the pharmaceutical industry resp. With the cost bearers (health insurance, etc.) a distinction is made between "total pharmaceutical market", "total pharmacy market" and "GKV market". The overall pharmaceutical market can be divided into a hospital (or clinic / hospital) and pharmacy market. Market research companies such as B. IMS Health provide the data for this.

"Regulation, reforms, ethics and monetics"

“Since everything revolves around the patient or the prevention of illnesses in healthy people, this is not a usual, but rather a largely state-regulated“ market ”. The discussions today often revolve around more or less competition - for example between hospitals - and questions of competition law when several hospitals are merged. But also about terms such as “patient or customer”, because on the one hand patients are often not really free to choose or decide, but on the other hand they have an optimal willingness to provide services such as to customers B. in retirement and nursing homes, hospitals and doctors' offices. This also includes new questions and the necessary answers to maintain security of supply, especially in rural regions, when it no longer seems possible to fill country medical practices there. But then of course also to an appropriate training and work distribution, such as B. between medical and nursing health professions for possible delegation or even substitution of healing, examination and other health services ” . How important it is from the perspective of the insured to keep an eye on the forces of the health market is also shown by the pricing of drugs with almost continuously above-average price development until 2010 and the resulting changes in drug approval and in the drug price regulation . From these discussions it becomes clear that ethics and business ethics in the health market are outstanding topics for patients and all health insured persons as well as for medicine and nursing as well as health insurance companies, the state and the many other participants in this “market”. At the moment, this primarily includes questions of rationalization or even rationing, for example in the reimbursement of costs for medical and nursing services as well as pharmaceuticals and medical products under quality, cost and benefit aspects.

literature

  • Gunnar Duttge (Ed.): Tatort health market. Legal reality - punishability - prevention. In: Göttingen studies on criminal sciences. Volume 20, Göttingen 2011. ISBN 978-3-86395-028-6 online version (PDF file; 897 kB)

swell

  1. ↑ Federal Statistical Office: Employment in the health sector continues to rise. Press release No. 490, Berlin, December 17, 2008
  2. ^ AJW Goldschmidt : The "market" health system. In: M. Beck, AJW Goldschmidt, A. Greulich, M. Kalbitzer, R. Schmidt, G. Thiele (eds.): Management Handbuch DRGs, Hüthig / Economica, Heidelberg, 1st edition 2003 ( ISBN 3-87081-300 -8 ): S. C3720 / 1-24, with 3 revisions / additional deliveries until 2012
  3. ↑ Leo Nefiodow: The sixth Kondratieff: Paths to productivity and full employment in the age of information , Sankt Augustin, 1996: Rhein-Sieg-Verlag ( ISBN 3-98051-443-9 )
  4. ↑ Erik Händeler: Kondratieff's World - Prosperity after Industrial Society, Brendow-Verlag, Moers 2005, ISBN 978-3-86506-065-5 )
  5. ↑ AJW Goldschmidt, J. Hilbert: From the burden to the chance - the paradigm shift from the health system to the health economy. In: AJW Goldschmidt, J. Hilbert (Hrsg.): Health economy in Germany. The future industry. Volume 1 of the series of publications: Health Economics and Management. kma-Reader - The library for managers. Wikom-Verlag (Thieme), Wegscheid, 2009 ( ISBN 978-3-9812646-0-9 ): pp. 20-40
  6. ↑ E. Dahlbeck, J. Hilbert: Employment trends in the health economy in regional comparison. Internet document. Gelsenkirchen: Inst. Work and technology. Research News, No. 06/2008 → www.iat.eu/forschung-aktuell/2008/fa2008-06.pdf
  7. ↑ Institute Work and Technology - DIMENSAAI / Diversity and Mentoring Approaches to Support Active Aging and Integration .
  8. ↑ Health economy at a glance .
  9. ^ J. Kartte, K. Neumann: The second health market. Understanding customers, seizing business opportunities, above: Roland Berger Strategy Consultants, Munich, 2007
  10. ↑ IMS Market Report Development of the German Pharmaceutical Market 2013 , IMS Health website, accessed on March 16, 2014, (PDF file; 322 kB)
  11. ↑ Summary of the keynote speech on the occasion of the fundraising campaign for Doctors Without Borders “Do good and talk about it!” At the Rhein-Main Future Congress on February 23, 2011 and the opening of the congress by AJW Goldschmidt → Archived copy ( memento of the original from November 2, 2014 on the Internet Archive ) Info: The archive link was inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice. @1@ 2Template: Webachiv / IABot / www.rhein-main-zukunftskongress.de
  12. ↑ M. Geiger, AJW Goldschmidt: Market and regulatory determinants for the price and sales of drugs. In: AJW Goldschmidt, J. Hilbert (Hrsg.): Health economy in Germany. The future industry. Volume 1 of the series of publications: Health Economics and Management. kma-Reader - The library for managers. Wikom-Verlag (Thieme), Wegscheid, 2009 ( ISBN 978-3-9812646-0-9 ): pp. 218-235
  13. ^ Discussions on "Ethics and Monetics" compiled from lectures between 1997 and 2011 by F. Breier, AJW Goldschmidt, W. Greiner, J. Hilbert and H. Lohmann